Ali et al., 2007 - Google Patents
Vitamin D and cancerAli et al., 2007
View HTML- Document ID
- 11960669512742990615
- Author
- Ali M
- Vaidya V
- Publication year
- Publication venue
- Journal of cancer research and therapeutics
External Links
Snippet
Vitamin D, a fat-soluble prohormone is synthesized in response to sunlight. Experimental evidence suggests that vitamin D may reduce the risk of cancer through regulation of cellular proliferation and differentiation as well as inhibition of angiogenesis. These anticancer …
- 229930003316 Vitamin D 0 title abstract description 64
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ali et al. | Vitamin D and cancer | |
| Moridi et al. | The association between vitamin D and anti-Müllerian hormone: a systematic review and meta-analysis | |
| Bouillon et al. | Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions | |
| Ebeling et al. | Management of endocrine disease: therapeutics of vitamin D | |
| Al Mheid et al. | Vitamin D and cardiovascular disease: controversy unresolved | |
| Antonucci et al. | Vitamin D deficiency in childhood: old lessons and current challenges | |
| Wimalawansa | Vitamin D in the new millennium | |
| Engel et al. | Serum 25 (OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort | |
| Crew et al. | Association between plasma 25-hydroxyvitamin D and breast cancer risk | |
| Field et al. | Melanoma and vitamin D | |
| Meckel et al. | Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis | |
| Bertone-Johnson et al. | Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of breast cancer | |
| Ng et al. | Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741 | |
| Lappe et al. | Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial | |
| Hansen et al. | Do proton pump inhibitors decrease calcium absorption? | |
| Lamberg-Allardt et al. | Vitamin D–a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations | |
| Peterson et al. | Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women | |
| Stolzenberg-Solomon et al. | Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial | |
| Manicourt et al. | Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer | |
| Al-Musharaf et al. | Vitamin D deficiency and calcium intake in reference to increased body mass index in children and adolescents | |
| Shah et al. | Maternal hypercalcemia due to failure of 1, 25-dihydroxyvitamin-D3 catabolism in a patient with CYP24A1 mutations | |
| Berndt et al. | Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging | |
| Szulc et al. | Serum concentrations of 17β‐E2 and 25‐hydroxycholecalciferol (25OHD) in relation to all‐cause mortality in older men–the MINOS study | |
| Beasley et al. | Alcohol and risk of breast cancer in Mexican women | |
| Bhagatwala et al. | Dose and time responses of vitamin D biomarkers to monthly vitamin D3 supplementation in overweight/obese African Americans with suboptimal vitamin d status: a placebo controlled randomized clinical trial |